Your session is about to expire
← Back to Search
Intervention Group for Cardiac Surgery (POAM Trial)
POAM Trial Summary
This trial is being conducted at three cardiac surgery centers in Canada to see if giving intravenous iron therapy to patients with chronic iron-deficiency anemia after cardiac surgery can improve their outcomes compared to a placebo
POAM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.POAM Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any available openings for patients to participate in this medical study?
"As per clinicaltrials.gov, this particular research endeavor is not actively seeking participants. The trial was introduced on April 1st, 2024, and last revised on February 23rd, 2024. Although recruitment for this study is currently closed, it's noteworthy that there are a substantial number of other trials - precisely 312 - accepting new enrollees presently."
Has the intervention group received approval from the FDA?
"Based on our assessment at Power, the safety rating for the Intervention Group in this Phase 2 trial is a 2. This indicates that while there is existing data supporting its safety profile, efficacy data remains preliminary or absent."
Share this study with friends
Copy Link
Messenger